Skip to main content

Health Wildcatters


Last Tuesday I attended a kickoff meet-and-greet for Health Wildcatters, a new Dallas-based healthcare-oriented seed accelerator. My impression of the event? Electrifying. The venue ("Tech Church," headquarters for both Health Wildcatters and its older sibling Tech Wildcatters) was filled to the brim with people collectively representing an incredibly diverse array of business and technical expertise. For an illustration of the diversity of talent present within Health Wildcatters' orbit, take a look at the profiles of the mentors (58 in all) who have signed up to serve as coaches for its incoming startups. I had the fortune of having conversations with a number of them at the event. One was with Charley KiserPresident & CEO of management consultancy C. H. Kiser & Company, LLC, who told me that the difficulties that exist in sharing patient information between hospitals is driven only partially by technical constraints (e.g., lack of compatibility between different EHR systems, etc.) and that the lack of business incentives for hospitals to streamline data sharing may in fact be a bigger driver. Another was with David Sym-Smith, Partner at Mobility Ventures, who expressed incredible enthusiasm about the potential of mobile technologies to upend current models of healthcare delivery, up to and including the dissolution of hospitals as they currently exist. Taken in the aggregate, the level of talent and experience represented by the mentors on board at Health Wildcatters is amazing and bodes well for its success.

Go to http://healthwildcatters.com/news/ to see all of the media coverage Health Wildcatters has received. Photos from the meet-and-greet event can be found here and here.  


- Isamu Z. Hartman, PhD

Comments

Popular posts from this blog

Comics About Patents (A Work In Progress)

Back in January and February of 2018, I spent some time creating two four-panel comics about the process of 1) obtaining patent protection, and 2) monetizing those patent rights by licensing them. I drew the comics to serve as an illustration of concepts that I often find myself explaining to others in the course of my work. I've already shared these comics through  Twitter  and  Facebook  (click on either of link to see more of the creative process!). However, I thought I'd share them with my blog's readership as well. Please enjoy! I'm really hoping to reignite this project at some point in the future and create more episodes. (Click on the images below to enlarge) Episode 1: Episode 2: - Isamu Hartman

The Big Fish: Texas-Based Biomedical Companies listed on NYSE and NASDAQ

[Monday, 22 April 2013:  I added Hanger Inc. (HGR, NYSE), an Austin-based prosthetics and orthotics company I had originally missed, to the list] [Thursday, 02 May 2013:  fixed the location of Hanger Inc. (HGR, NYSE) - changed from Dallas to Austin] I have another few posts coming up on Texas-based awardees of the SBIR program. But first, a quick digression. +Levi Shapiro  asked me the following question during a phone conversation we had earlier today:  who are the "Big Players" in the Texas biomedical industry that are listed in the major stock exchanges? I knew about Luminex (LMNX, NASDAQ) off the top of my head. Other than that, though, I really had no idea. Following the advice of +Lauren Nise  , I used LexisNexis (courtesy of the UT Dallas Eugene McDermott Library ) to generate a list of publicly traded biomedical companies headquartered in Texas that are listed in either NYSE or NASDAQ. Here are the companies I found: (Open spreadsheet as a se...

Developing Software: What Should Academic Researchers Keep in Mind? (Part 1)

Having never had any experience in software development when I entered the world of academic technology transfer back in 2013, I never expected to learn so much in the intervening years about software licensing and commercialization. It turns out that, even working in technology transfer at a medical institution, I encounter a surprising number of software-based technologies. Furthermore, with the recent rise in the use of AI/ML applications in biomedical research, the frequency at which I am presented with software in my work is only increasing.  Below is my first attempt at summarizing what I have learned thus far in managing software assets within an academic technology transfer setting. None of what I write here should be viewed as constituting legal advice. Furthermore, if you are an academic researcher, you should most definitely rely on the guidance you receive from your own institution’s own technology transfer office when navigating these waters! However, I’m sharing my ob...